Literature DB >> 9203704

Surveillance for polio eradication in the People's Republic of China.

J Zhang1, L B Zhang, M W Otten, T Jiang, X L Zhang, R Z Zhang, K A Wang.   

Abstract

A case-based virus surveillance system for wild poliovirus in China was developed. By 1993, all 30 provincial immunization units and, by 1994, all 29 provincial laboratories were sending computerized data to the national level. In 1993, a county-level, computerized map was operationalized that permitted visual monitoring of the progress of the polio eradication program every month by county. In 1993, wild poliovirus type 1 was detected in 8 provinces. Wild poliovirus mainly caused clusters of polio cases identified by a surveillance system that detected primarily clinical polio in children <5 years old (1 stool sample was collected on approximately 50% of reported cases). By 1995, the surveillance system had reached certification-like levels (80% of acute flaccid paralysis [AFP] patients with 2 stool specimens and AFP case rate of 1/100,000 children <15 years old). No indigenous wild poliovirus was detected in 1995. This general case-based model can be applied to measles and other important diseases, and may then lead to a more rapid decrease in adverse health outcomes.

Entities:  

Mesh:

Year:  1997        PMID: 9203704     DOI: 10.1093/infdis/175.supplement_1.s122

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Jong-Hoon Kim; Cara C Burns; Olen M Kew; M Steven Oberste; Ousmane M Diop; Steven G F Wassilak; Stephen L Cochi; Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-07       Impact factor: 4.000

2.  Environmental Surveillance Complements Case-Based Surveillance of Acute Flaccid Paralysis in Polio Endgame Strategy 2019-2023.

Authors:  Peng Chen; Yao Liu; Haiyan Wang; Guifang Liu; Xiaojuan Lin; Weiyan Zhang; Feng Ji; Qing Xu; Zexin Tao; Aiqiang Xu
Journal:  Appl Environ Microbiol       Date:  2020-07-20       Impact factor: 4.792

3.  Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China.

Authors:  H M Liu; D P Zheng; L B Zhang; M S Oberste; M A Pallansch; O M Kew
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China.

Authors:  Dongmei Yan; Li Li; Shuangli Zhu; Yong Zhang; Junjing An; Dongyan Wang; Ning Wen; Jaume Jorba; Wei Liu; Ge Zhong; Lin Huang; Olen Kew; Xiaofeng Liang; Wenbo Xu
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

5.  Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.

Authors:  Hong-Mei Liu; Du-Ping Zheng; Li-Bi Zhang; M Steven Oberste; Olen M Kew; Mark A Pallansch
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  From emergence to eradication: the epidemiology of poliomyelitis deconstructed.

Authors:  Neal Nathanson; Olen M Kew
Journal:  Am J Epidemiol       Date:  2010-10-26       Impact factor: 4.897

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.